Carl Kay, MD

Army GI @CRDAMC | Asst Prof of Med @USUhealthsci Husband | Girl Dad x2 | Interests: 26.2, QI, & #MedEd via @SAUSHEC_GI @IUMedSchool & @WheatonCollege

[Carl Kay, MD @CarlKayMD]

1/ Collated thread for new GI fellows

⭐️GI Fellow Resources ⭐️

▪️Websites
▪️Guidelines
▪️Apps
▪️Podcasts
▪️Textbooks
▪️Board study
▪️Social media

📲 https://t.co/hhrVBhUDQq (hyperlinked 📄)

#GITwitter

[Carl Kay, MD @CarlKayMD]

@AlmomaniMD @ASGEendoscopy @GIE_Journal Here’s the link:

https://t.co/QlMZNWdbWP

[Carl Kay, MD @CarlKayMD]

New USMSTF SPS consensus:
▪️~1/250 screening, often missed
▪️Use WHO 2019 criteria
▪️Keep and document lifetime count
▪️SSLDR ≥6%
▪️Cold resection!
▪️Clear q3–6 mo → q1–2 yr

https://t.co/6enZ4oTnKG

[Carl Kay, MD @CarlKayMD]

@AlmomaniMD Why not take biopsies AFTER dilation? If no dilation effect, use biopsy forceps for mechanical disruption of the Schatzki ring

Pro-tip: ensure you have already obtained biopsies so you don’t confound histology findings. Ie don’t send tissue from Schatzki ring.

[Elliot Tapper @ebtapper]

I have received multiple faxes from @ExpressScripts telling me that carvedilol is “contraindicated” for patients with cirrhosis

This is not acceptable and could result is patient harm if someone were to stop this medication. I advise them to stop this practice

[Carl Kay, MD @CarlKayMD]

@ebtapper @ExpressScripts So glad you are bringing this up!

[Carl Kay, MD @CarlKayMD]

🆕 ACG Guideline Highlights: Adenomatous Colorectal Polyposis Syndromes 🧬

▪️Germline testing triggers + MGPT panel
▪️FAP/AFAP/MAP surveillance intervals
▪️Gastric & duodenal (Spigelman) mgmt

Proud to have contributed concept & content

🔗https://t.co/u45piJONUr

[Carl Kay, MD @CarlKayMD]

@TheGastrologer @prakashini_ Esp when the slides/ppt are distracting from the paradoxically higher quality delivery!

[Carl Kay, MD @CarlKayMD]

@TheGastrologer @jgarciacano1 Agreed. This looks like good therapeutic effect.

Would be curious to hear more about Savary technique used. Known starting stricture diameter? Empiric starting size? Sequential dilation? Resistance? How much?

[Carl Kay, MD @CarlKayMD]

@TheGastrologer @Samir_Grover @AmerGastroAssn 💯

[Carl Kay, MD @CarlKayMD]

@GI_Pearls But a salient point… it’s important for everyone (including GI folks) to look at nutritional contents, rather than merely assessing the degree of “ultra processed.”

[Carl Kay, MD @CarlKayMD]

@GI_Pearls Well, at least based on the article referenced, ultra processed foods are commonly associated with less fiber and more sugar.

Hard to find consistently equivalent/matched nutritional contents in ultra processed foods.

I feel some sensationalism/contrarianism in the article.

[Carl Kay, MD @CarlKayMD]

Great weekend at @AmCollegeGastro Early Career Leadership Course ‘26! Honored to take part!

Highly recommend introspective assessments like:
▪️ Ikigai
▪️Hogan assessment
▪️Goleman leadership styles

Thank you @TrieuMD, @DrBloodandGuts, & @NeenaSAbrahamMD for an amazing course!

[Carl Kay, MD @CarlKayMD]

“MIRacle Sign” ➡️ inducible reversible blanching on EGD with CO2 insufflation. Clue to diagnose borderline or overt gut ischemia

[The Practicing Endoscopist @theendoscopist]

Upper gastrointestinal (GI) endoscopy or esophagogastroduodenoscopy (EGD) continues to be an extremely useful diagnostic tool for perspicuous macroscopic findings.

Read the full case: https://t.co/5eVmHstTvj

[Beatriz Gros @Bealoquebea]

Lately, I keep hearing that IFX is the only drug with clinical trial in perianal Crohn’s...🧐

So, I’ve updated my cheat sheet on medical therapy trials in perianal CD, summarizing 15 RCTs into just one page. Hope it’s useful! Surgical part coming soon

(If any is missing please let me know and I will add it)
⏳➡️https://t.co/j5g7lBDRdD

[Achintya Singh, MD @AchintyaSinghMD]

The 'pits' on the polyp are base or openings of the crypts.

This paper (bookmark!) details the 3D dimension of the crypts: https://t.co/mSNvD9IpEN

As the cells proliferate, the gland architecture distorts, so does the pit pattern.

Used in Kudo, JNET, NICE classification

[Papa Heme @Papa_Heme]

AI is not gonna replace physicians. However, physicians who don’t utilize AI will be replaced. When I am sick I want AI going through all my data and then render an opinion and an excellent clinician doing the same. Then the two of them can work together to fix me.

[Joseph Sleiman, MD, FACP @JosephHabibi_MD]

#CGH4ALL @AGA_CGH
📣 Exciting data in #EoE: A potential step toward restoring dietary freedom while maintaining disease control in EoE.

🔹Open-label pilot study, patients (6–25 yrs) w/ milk/egg/soy/wheat-triggered EoE
🔹Dupilumab for 3 months, followed by stepwise food reintroduction up to 12 months
🔹All completers successfully reintroduced ≥1 trigger food, and many expanded diets every 3 months

#GITwitter #MedTwitter

🔗https://t.co/dManUlSOps

Reported by @AasthaBharwad

@EdoardoSavarino, @NdeBortoli, @SebastianZeki, @stevenbollipo, @DrCJudge, @my_ueg, @virgisolitano, @eathar_s, @DaniyalAbbasMD

[Clive Miranda, DO, MSc @clivejmiranda]

✨ Thank you @gastroendonews for having @JosephHabibi_MD and myself 🗣️ about our latest 📝 on building your social media brand as a GI trainee 🎙️

Grateful to all our coauthors! 🙏🏻 @BilalMohammadMD @CarlKayMD

The hard copy is out! Read it today 🫵
📜 https://t.co/q13JdPlyoS

[Ramon Bataller @rabataller]

First double-blind, placebo-controlled RCT in @TheLancet showing that SEMAGLUTIDE reduces ALCOHOL intake in people with BMI >25.

Potentially practice-changing.

https://t.co/8RgqyoA3sp